Shares of Stem, Inc. (NYSE:STEM – Get Free Report) have earned a consensus rating of “Hold” from the nine ratings firms that are covering the stock, MarketBeat reports. Seven research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $1.90.
A number of analysts have commented on the stock. The Goldman Sachs Group reduced their price objective on shares of Stem from $0.75 to $0.65 and set a “neutral” rating for the company in a research note on Friday. UBS Group reduced their price objective on shares of Stem from $2.50 to $1.00 and set a “buy” rating for the company in a research note on Thursday, August 8th. Evercore ISI reduced their price objective on shares of Stem from $9.00 to $5.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Barclays reduced their price objective on shares of Stem from $4.00 to $1.00 and set an “equal weight” rating for the company in a research note on Friday, October 18th. Finally, Susquehanna upped their price objective on shares of Stem from $0.50 to $0.60 and gave the company a “neutral” rating in a research note on Wednesday, October 16th.
Read Our Latest Stock Analysis on STEM
Stem Stock Performance
Stem (NYSE:STEM – Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. Stem had a negative net margin of 328.11% and a negative return on equity of 87.61%. The company had revenue of $34.00 million during the quarter, compared to analyst estimates of $64.06 million. During the same quarter last year, the firm posted ($0.56) EPS. The business’s revenue for the quarter was down 63.4% on a year-over-year basis. On average, sell-side analysts anticipate that Stem will post -0.52 earnings per share for the current fiscal year.
Institutional Trading of Stem
A number of hedge funds have recently made changes to their positions in STEM. Vanguard Personalized Indexing Management LLC bought a new position in Stem during the second quarter valued at approximately $30,000. Nisa Investment Advisors LLC raised its position in Stem by 2,416.1% during the second quarter. Nisa Investment Advisors LLC now owns 28,507 shares of the company’s stock valued at $32,000 after acquiring an additional 27,374 shares in the last quarter. SG Americas Securities LLC raised its position in Stem by 73.9% during the second quarter. SG Americas Securities LLC now owns 33,666 shares of the company’s stock valued at $37,000 after acquiring an additional 14,307 shares in the last quarter. Creative Planning raised its position in Stem by 177.1% during the third quarter. Creative Planning now owns 123,521 shares of the company’s stock valued at $43,000 after acquiring an additional 78,940 shares in the last quarter. Finally, Cetera Advisors LLC bought a new position in Stem during the first quarter valued at approximately $179,000. 61.63% of the stock is owned by hedge funds and other institutional investors.
About Stem
Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.
See Also
- Five stocks we like better than Stem
- How to Most Effectively Use the MarketBeat Earnings Screener
- Intel: Is Now the Time to Be Brave?Â
- What is a Special Dividend?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.